Who we are
The Lung Cancer Group Cologne (LCGC) was founded at the Centre for Integrated Oncology (CIO) at University Hospital Cologne in 2005. At LCGC doctors and scientists work together with their teams to improve the therapy for lung cancer. We are convinced that to accomplish this, understanding the biological principles of lung cancer, an accurate molecular diagnosis and clinical studies that are based on biological comprehension have to go hand in hand with each other. That is why at LCGC there is a permanent exchange between the study center and the work groups of molecular pathology, cancer genomics and molecular imaging. In addition to developing new therapy approaches, we want to ensure that all of our patients get a therapy that is based on the most recent knowledge. For this we are in contact with internationally leading groups as well.
On this website we want to give you an insight into our research programs and our clinical studies program and provide you with the possibility of contacting us.
The team working at the LCGC study center, led by prof Jürgen Wolf, is located at the Clinic I for Internal Medicine at the Center for Integrated Oncology at University Hospital Cologne. Our goal is the development of effective therapy approaches for lung cancer.
For this we develop our own study reports for treating lung cancer, always in exchange with the working groups of molecular pathology, translational cancer genomics and molecular imaging. In addition to this, we want to offer our patients an extensive supply of studies with new medicine or therapy approaches for their cancer, working together with the pharmaceutical industry.
The LCGC study program particularly aspires to offer every patient a specific study with a therapeutically relevant genetic aberration in his tumor. To achieve this for as many patients as possible, the doctors working at the LCGC study center also supervise the Network Genomic Medicine Lung Cancer. Also, the LCGC doctors work at the special ambulances of the center for integrated oncology and at the stations of Clinic I for Internal Medicine at University Hospital Cologne to guarantee an optimal care for lung cancer patients in Cologne.